Adam R Craig Cti Biopharma Corp (CTIC) insider trading activity
Adam R Craig is President and CEO of CTI BIOPHARMA CORP. Currently has a direct ownership of 0 shares of CTIC, which is worth approximately $0. The most recent transaction as insider was on Jun 03, 2022, when has been sold 18,223 shares (Common Stock) at a price of $0.84 per share, resulting in proceeds of $15,307. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Adam R Craig Transaction History
ARC
Adam R Craig
President and CEO
Seattle, WA